Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)

Add time:08/29/2019    Source:sciencedirect.com

Aldo-keto reductase 1C3 (AKR1C3) also known as type 5 17β-hydroxysteroid dehydrogenase has been implicated as one of the key enzymes driving the elevated intratumoral androgen levels observed in castrate resistant prostate cancer (CRPC). AKR1C3 inhibition therefore presents a rational approach to managing CRPC. Inhibitors should be selective for AKR1C3 over other AKR1C enzymes involved in androgen metabolism. We have synthesized 2-, 3-, and 4-(phenylamino)benzoic acids and identified 3-(phenylamino)benzoic acids that have nanomolar affinity and exhibit over 200-fold selectivity for AKR1C3 versus other AKR1C isoforms. The AKR1C3 inhibitory potency of the 4′-substituted 3-(phenylamino)benzoic acids shows a linear correlation with both electronic effects of substituents and the pKa of the carboxylic acid and secondary amine groups, which are interdependent. These compounds may be useful in treatment and/or prevention of CRPC as well as understanding the role of AKR1C3 in endocrinology.

We also recommend Trading Suppliers and Manufacturers of 2-(Diphenylphosphino)benzoic acid (cas 17261-28-8). Pls Click Website Link as below: cas 17261-28-8 suppliers

Prev:Enantiomerically divergent pathways in Tsuji-Trost reactions: exploiting the structural differences between β-acyloxy-o-(diphenylphosphino)benzamides and β-amido-o-(diphenylphosphino)benzoates
Next:Syntheses and crystal structures of a series of new divalent metal phosphonates with imino-bis(methylphosphonic acid))